Financial statement analysis is often divided into two sub-parts i.e. “Profitability Analysis” and “Risk Analysis”. This is a natural division since much of our thinking about any firm’s performance is influenced by our study of the relationship between risk and return in finance. This paper represents an empirical study which examines the profitability from different perspectives of Pharmaceutical industries in India with a data of 10 years from 2002 to 2011 and 07 major pharmaceutical companies have been considered as sample units. For this analytical study, the researcher has used Ratio Techniques for analysis and to test hypothesis Single Factor ANOVA (F-test) has been applied. The study reveals that Glaxosmithkline remained an outperforming player over the last decade in the pharmaceutical industry with leading in the profitability from the different perspectives and Ranbaxy could not match the pace of the profitability with that of the industry average
S. Vishal (Sat,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: